| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |